Ituran Location & Control Bolsa (NASDAQ: ITRN)

Últimas noticias sobre Ituran Location & Control (NASDAQ:ITRN) Bolsa

Ituran Location & Control

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services, and Telematics products. The Telematics services segment consists of regionally- based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location, and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others.

Ituran Location and Control Ltd. - Ordinary Shares

Ituran Location and Control Ltd

Barclays analyst Tavy Rosner maintains Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) with a Overweight and raises the price target from $35 to $50.

News

Price Target

Analyst Ratings

ITRN

Barclays Maintains Overweight on Ituran Location & Control, Raises Price Target to $50

Ituran Location Declared 25% Increase To Dividend Policy To $10M, Or $0.50 Per Share Per Quarter, From $8M In Recent Prior Quarters

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.68 by 2.94 percent. This is a 16.67 percent increase over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $82.88 million which beat the analyst consensus estimate of $81.81 million by 1.31 percent. This is a 6.52 percent increase over sales of $77.81 million the same period last year.

Earnings

Earnings Beats

Ituran Location & Control Q4 EPS $0.70 Beats $0.68 Estimate, Sales $82.88M Beat $81.81M Estimate

AAOI

ABEV

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARIS

ARKO

ASTE

ATEC

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.63 by 9.52 percent. The company reported quarterly sales of $83.749 million which missed the analyst consensus estimate of $86.200 million by 2.84 percent. This is a 3.33 percent increase over sales of $81.053 million the same period last year.

Earnings Misses

Ituran Location & Control Q3 2024 GAAP EPS $0.69 Beats $0.63 Estimate, Sales $83.749M Miss $86.200M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) is likely to report quarterly earnings at $0.13 per share on revenue of $690.99 million. 
• Nano X Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNOX#NASDAQ">NNOX</a>) is expected to report quarterly loss at $0.15 per share on revenue of $3.53 million. 
• Warner Music Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) is estimated to report quarterly earnings at $0.31 per share on revenue of $1.60 billion. 
• Construction Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROAD#NASDAQ">ROAD</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $538.05 million. 
• Cerence (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNC#NASDAQ">CRNC</a>) is projected to report quarterly loss at $0.38 per share on revenue of $47.65 million. 
• BJ's Wholesale Club (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) is projected to report quarterly earnings at $0.93 per share on revenue of $5.11 billion. 
• Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) is projected to report quarterly earnings at $0.66 per share on revenue of $85.44 million. 
• Baozun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZUN#NASDAQ">BZUN</a>) is projected to report earnings for its third quarter. 
• Shoe Carnival (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $316.23 million. 
• Atkore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATKR#NYSE">ATKR</a>) is projected to report quarterly earnings at $2.47 per share on revenue of $748.32 million. 
• iQIYI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQ#NASDAQ">IQ</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $1.02 billion. 
• GreenTree Hospitality Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHG#NYSE">GHG</a>) is likely to report earnings for its third quarter. 
• PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) is projected to report quarterly earnings at $2.82 per share on revenue of $14.47 billion. 
• Deere (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) is projected to report quarterly earnings at $3.87 per share on revenue of $9.35 billion. 
• KE Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $3.23 billion. 
• Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) is expected to report quarterly earnings at $2.35 per share on revenue of $4.69 billion. 
• Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) is likely to report earnings for its third quarter. 
• Evogene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGN#NASDAQ">EVGN</a>) is projected to report quarterly loss at $1.01 per share on revenue of $2.85 million. 
• Lotus Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) is expected to report earnings for its third quarter. 
• RealReal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAL#NASDAQ">REAL</a>) is projected to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Copart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRT#NASDAQ">CPRT</a>) is estimated to report quarterly earnings at $0.37 per share on revenue of $1.10 billion. 
• UGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UGI#NYSE">UGI</a>) is likely to report quarterly loss at $0.29 per share on revenue of $1.65 billion. 
• Matthews International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATW#NASDAQ">MATW</a>) is likely to report quarterly earnings at $0.38 per share on revenue of $440.46 million. 
• Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $3.81 billion. 
• Logility Supply Chain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGTY#NASDAQ">LGTY</a>) is projected to report quarterly earnings at $0.09 per share on revenue of $25.93 million. 
• Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $354.28 million. 
• Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) is estimated to report quarterly earnings at $1.40 per share on revenue of $5.15 billion. 
• NetApp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NASDAQ">NTAP</a>) is estimated to report quarterly earnings at $1.78 per share on revenue of $1.64 billion. 
• Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) is estimated to report quarterly earnings at $2.36 per share on revenue of $3.14 billion. 
• Geospace Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEOS#NASDAQ">GEOS</a>) is projected to report earnings for its fourth quarter. 
• Natural Grocers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGVC#NYSE">NGVC</a>) is expected to report earnings for its fourth quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATKR

BEKE

BIDU

BZUN

CPRT

CRNC

ESTC

EVGN

GEOS

INTU

LGTY

MATW

NGVC

NNOX

NTAP

Citigourp Global Markets 2% Protected Notes Linked To The Djia

REAL

ROAD

ROST

SCVL

VSTS

Earnings Scheduled For November 21, 2024

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) is gearing up to announce its quarterly earnings on Thursday, 2024-11-21. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Ituran Location &amp; Control will report an earnings per share (EPS) of $0.66.
The announcement from Ituran Location &amp; Control is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Overview of Past Earnings</h3>
The company's EPS beat by $0.05 in the last quarter, leading to a 2.62% increase in the share price on the following day.
Here's a look at Ituran Location &amp; Control's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.61</td>
<td>0.59</td>
<td>0.6</td>
<td>0.58</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.66</td>
<td>0.66</td>
<td>0.6</td>
<td>0.63</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>-0.0%</td>
<td>1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1732111366_0.png" alt="eps graph" />
<h3>Market Performance of Ituran Location &amp; Control's Stock</h3>
Shares of Ituran Location &amp; Control were trading at $27.18 as of November 18. Over the last 52-week period, shares are up 9.29%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/ITRN/earnings">To track all earnings releases for Ituran Location &amp; Control visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Ituran Location & Control's Earnings Preview

Ituran Location and Control Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>), a global leader in vehicle telematics, today announced that following its long-term partnership with Nissan in Mexico, Ituran's subsidiary in Chile has signed a 5-year contract with Nissan Chile. Under this agreement, Ituran will provide the Vehicle Location Unit (VLU) and a suite of telematics and stolen vehicle recovery (SVR) services to Nissan and its customers throughout Chile.
Following their car purchase, Nissan's customers will enjoy a one year free trial of Ituran's service which will be paid for by Nissan. This agreement will initially cover three vehicle models, with an expected addition of tens of thousands of vehicles over the years. The VLU unit will be pre-installed in these models before reaching the dealers.
Customers will have access to a comprehensive Nissan-branded on-vehicle application. Additionally, the customers will also have access to Ituran Chile's 24-hour contact center, assistance in the event of vehicle theft, and emergency services such as breakdown assistance and towing.

Global

Ituran And Nissan Sign A Contract For Vehicle Tracking And Recovery Services In Chile

The subscriber base expanded to 2,329,000 by the end of June 2024, marking an increase of 38,000 from the previous quarter.
 &nbsp;

Ituran Location and Control Added 38K Subscribers In Q2

Guidance for 2024
Overall, looking ahead to 2024, management reiterates its expectations for continued revenue and profit growth, adding approximately 35,000 to 40,000, net new subscribers per each quarter throughout 2024.
From a financial perspective, full-year 2024 EBITDA expectations continue to be between $90-95 million and 2025 EBITDA is targeted to surpass $100 million. The current guidance assumes that the exchange rates in the geographies in which Ituran operate do not worsen against the US dollar, and the current global macro-economic situation and the political situation in Israel do not materially deteriorate.

Guidance

Ituran Location and Control Reiterated Continued Revenue And Profit Growth For FY24, Adding 35K-40K New Subscribers/Quarter Throughout 2024

Ituran Location & Control Q2 2024 GAAP EPS $0.66 Beats $0.60 Estimate, Sales $84.869M Miss $86.100M Estimate

General

Ituran Location and Control Ltd. Announces Partnership With Microsoft and Porsche For Real-Time Telemetry Data

Overall, looking ahead to 2024, management reiterates its expectations for continued revenue growth and profitability throughout the year.
Management continues to expect to add approximately 35,000 to 40,000, net new subscribers per each quarter during 2024.
From a financial perspective, full-year 2024 EBITDA expectations continue to be between&nbsp;$90-95 million and 2025 EBITDA is targeted to surpass&nbsp;$100 million.
It is noted that these targets are based on current exchange rates and assumes that the current global macro-economic situation and political situation in&nbsp;Israel&nbsp;does not significantly worsen.

Ituran Location 2024 EBITDA Expectations Continue To Be Between $90M-95M, 2025 EBITDA Is Targeted To Surpass $100M

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.59 by 11.86 percent. This is a 17.86 percent increase over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $85.03 million which missed the analyst consensus estimate of $85.70 million by 0.79 percent. This is a 6.99 percent increase over sales of $79.47 million the same period last year.

Ituran Location & Control Q1 EPS $0.66 Beats $0.59 Estimate, Sales $85.03M Miss $85.70M Estimate

Dividends

Ituran Location And Control Increases Dividend To 6%

Monday marks the last chance for investors to receive the next dividend payout from Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>). 
<h3>What's Happening</h3>
The company announced on Wednesday that it would pay shareholders a quarterly dividend of 39 cents per share. On Tuesday, Ituran Location &amp; Control will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 39 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Tuesday. Shareholders who own ITRN as of the end of Monday's session are eligible to receive the 39 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on April 03, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To stay up-to-date with the companies that are announcing their dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Monday Is Your Last Chance To Buy Ituran Location & Control Before The Dividend Payout

Shares of Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose sharply during Monday&rsquo;s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.
Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Kidpik Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pik#NASDAQ">PIK</a>) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares surged 149% to $2.6450.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share.</li>
<li>Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company&#39;s Southeast Asia data center business.</li>
<li>Solidion Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sti#NASDAQ">STI</a>) rose 23.3% to $0.9620.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024.</li>
<li>Bally&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baly#NYSE">BALY</a>) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally&#39;s proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company.</li>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) climbed 21.2% to $3.43. Rail Vision received an order from a Class 1 US railroad company for its AI-based safety system.</li>
<li>Marpai, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrai#NASDAQ">MRAI</a>) gained 18.7% to $2.0899.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biaf#NASDAQ">BIAF</a>) climbed 18.3% to $1.81.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxeh#NASDAQ">LXEH</a>) gained 15.6% to $4.8797.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) jumped 13.4% to $2.4650 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.</li>
<li>NWTN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwtn#NASDAQ">NWTN</a>) gained 13.4% to $4.8082.</li>
<li>Pulse Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plse#NASDAQ">PLSE</a>) rose 12.7% to $10.86. Pulse Biosciences announced FDA 510(k) clearance for Cellfx NSPFA Percutaneous Electrode System.</li>
<li>Bilibili Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bili#NASDAQ">BILI</a>) gained 12.7% to $12.55 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $10 to $11. The stock is also gaining amid overall China strength following the annual National People&#39;s Congress event.</li>
<li>Graphite Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grph#NASDAQ">GRPH</a>) climbed 11.7% to $3.5080. Graphite Bio declared a special dividend in connection with proposed merger with Lenz Therapeutics.</li>
<li>STAAR Surgical Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/staa#NASDAQ">STAA</a>) jumped 10% to $39.45 after Stifel upgraded the stock from Hold to Buy and raised its price target from $30 to $50.</li>
<li>VNET Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnet#NASDAQ">VNET</a>) rose 9.8% to $1.68.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) gained 9.2% to $112.51.</li>
<li>Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) climbed 7.8% to $28.42.</li>
<li>NuScale Power Corporation(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) gained 7% to $5.87. NuScale Power is expected to release fourth quarter results on March 14, 2024.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 4.7% to $1,492.07 amid continued strength in Bitcoin.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) fell 45.2% to $0.8650.</li>
<li>Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) shares fell 20.9% to $11.00 after the company announced downbeat quarterly earnings.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cero#NASDAQ">CERO</a>) declined 22% to $3.0822 after jumping 28% on Friday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.</li>
<li>The Real Good Food Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgf#NASDAQ">RGF</a>) fell 19.7% to $0.5536.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) dipped 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) fell 15.3% to $6.78 after declining 8% on Friday. Lytus Technologies, last week, announced the launch of Lytus Cloud.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) declined 15.3% to $0.0727.</li>
<li>MoneyLion Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ml#NYSE">ML</a>) fell 15% to $63.36.</li>
<li>Semilux International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/selx#NASDAQ">SELX</a>) fell 14.8% to $1.4403 after jumping 69% on Friday.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) fell 14.6% to $6.83.</li>
<li>Barnes &amp; Noble Education, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bned#NYSE">BNED</a>) dipped 13.8% to $0.7832. Barnes &amp; Noble Education recently rescheduled its third quarter fiscal year 2024 earnings release.</li>
<li>Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) fell 13.4% to $1.8272 after jumping 66% on Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.</li>
<li>Immuron Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrn#NASDAQ">IMRN</a>) shares tumbled 12.5% to $3.3252 after dipping 16% on Friday.</li>
<li>Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) fell 12% to $16.67 following fourth-quarter results.</li>
<li>Nanobiotix S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbtx#NASDAQ">NBTX</a>) dipped 9.8% to $6.35.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxi#NASDAQ">ATXI</a>) fell 8.9% to $0.1749 after surging 10% on Friday.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) dipped 8.8% to $1,039.60.</li>
<li>MannKind Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnkd#NASDAQ">MNKD</a>) declined 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstx#NASDAQ">PSTX</a>) fell 8.1% to $3.74.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37584162/wall-streets-most-accurate-analysts-say-buy-these-3-energy-stocks-with-over-3-dividend-y"> Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 3% Dividend Yields</a>

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ATXI

BALY

BIAF

BILI

BNED

CERO

EGOX

ELTK

GRPH

IMRN

JFBR

LXEH

LXRX

MEDS

MESO

MNKD

MRAI

MRNA

MSTR

NBTX

NWTN

PLSE

PSTX

RVSN

SELX

SMCI

STAA

TCBP

VNET

VTYX

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) reported quarterly earnings of $0.60 per share which met the analyst consensus estimate. The company reported quarterly sales of $77.81 million which missed the analyst consensus estimate of $82.80 million by 6.03 percent. This is a 3.82 percent increase over sales of $74.95 million the same period last year.

Ituran Location & Control Q4 2023 GAAP EPS $0.60, Inline, Sales $77.81M Miss $82.80M Estimate

Comments

Ituran Location & Control

Noticias

Últimas noticias sobre Ituran Location & Control (NASDAQ:ITRN) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL